|
HES1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2044999999915E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.002780E-03 |
| Normal-vs-Stage2 |
4.427000E-04 |
| Normal-vs-Stage3 |
1.520930E-03 |
| Normal-vs-Stage4 |
3.37500000002766E-06 |
| Stage1-vs-Stage2 |
2.667000E-01 |
| Stage1-vs-Stage3 |
5.540800E-01 |
| Stage1-vs-Stage4 |
8.637600E-03 |
| Stage2-vs-Stage3 |
5.288200E-01 |
| Stage2-vs-Stage4 |
4.017600E-01 |
| Stage3-vs-Stage4 |
1.089560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53540999999757E-05 |
| Normal-vs-AfricanAmerican |
1.005210E-01 |
| Normal-vs-Asian |
3.577200E-01 |
| Caucasian-vs-AfricanAmerican |
1.810410E-01 |
| Caucasian-vs-Asian |
6.024000E-01 |
| AfricanAmerican-vs-Asian |
9.239200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54900999999041E-05 |
| Normal-vs-Female |
1.362330E-03 |
| Male-vs-Female |
2.905600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.204220E-01 |
| Normal-vs-Age(41-60Yrs) |
5.135700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.85616999999194E-05 |
| Normal-vs-Age(81-100Yrs) |
8.416000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.205800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.128200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.625000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.590070E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.503760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.954200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.715200E-01 |
| Normal-vs-Grade 2 |
3.095700E-03 |
| Normal-vs-Grade 3 |
5.86129999999851E-05 |
| Normal-vs-Grade 4 |
4.21030000000711E-05 |
| Grade 1-vs-Grade 2 |
9.845900E-02 |
| Grade 1-vs-Grade 3 |
4.396400E-02 |
| Grade 1-vs-Grade 4 |
1.743720E-02 |
| Grade 2-vs-Grade 3 |
1.283380E-01 |
| Grade 2-vs-Grade 4 |
2.164300E-02 |
| Grade 3-vs-Grade 4 |
2.788400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.216400E-03 |
| Normal-vs-ccB subtype |
6.24020000006276E-07 |
| ccA subtype-vs-ccB subtype |
7.540000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.74930000000396E-05 |
| Normal-vs-N1 |
2.716200E-03 |
| N0-vs-N1 |
1.648970E-01 |
|
|
